Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

RUPALL

MEDEXUS PHARMACEUTICALS INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of RUPALL in Canada?

A shortage of RUPALL 1MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 14, 2026), but it has not started yet.

Why is RUPALL not available?

The reason the manufacturer reported: Delay in shipping of the drug.

When will RUPALL be available again?

The manufacturer's estimated resolution date is October 5, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file4 products
Expected resolution~7 days remaining (estimate)
Affected strength1MG
Last updated2026-09-14

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

APO-RUPATADINE

APOTEX INC

10MG · DIN 02553155

Different strengthDifferent dosage formSame routeNo current shortage

PMS-RUPATADINE

PHARMASCIENCE INC

10MG · DIN 02552604

Different strengthDifferent dosage formSame routeNo current shortage

RIVA-RUPATADINE

LABORATOIRE RIVA INC.

10MG · DIN 02560119

Different strengthDifferent dosage formSame routeNo current shortage

RUPALL

MEDEXUS PHARMACEUTICALS INC.

10MG · DIN 02456451

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02456478

Strength

1MG

Dosage Form

SOLUTION

Route

ORAL

Active Ingredient

RUPATADINE

See all RUPATADINE products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History